Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Paolo F. Caimi(Case Western Reserve University), Weiyun Z. Ai(University of California, San Francisco), Juan Pablo Alderuccio(Sylvester Comprehensive Cancer Center), Kirit M. Ardeshna(University College London), Mehdi Hamadani(Medical College of Wisconsin), Brian Hess(Medical University of South Carolina), Brad S. Kahl(Washington University in St. Louis), John Radford(National Institute for Health Research), Melhem Solh(Northside Hospital), Anastasios Stathis(Institute of Oncology Research), Pier Luigi Zinzani(University of Bologna), Karin Havenith, Jay Feingold, Shui He, Yajuan Qin, David Ungar, Xiaoyan Zhang, Carmelo Carlo‐Stella(Humanitas University)
Cited by 413
Abstract
Related Papers
No related papers found
Powered by citation graph analysis